| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |